Merck Global Health Innovation Fund

company

About

Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare

  • 1 - 10

Details

Industries
Finance,Health Care,Venture Capital
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
CVC

Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions.

Merck GHI has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck.

With a vision that data will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck's expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.

Investments

Number of Investments
Number of Lead Investments
9
2
Merck Global Health Innovation Fund has made 9 investments. Their most recent investment was on Dec 8, 2022, when TransVoyant raised $2.95M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 8, 2022 TransVoyant
Series Unknown $2.95M Analytics Yes
Jan 11, 2022 Transcarent
Series C $200M Health Care
Dec 16, 2021 Verge Genomics
Series B $98M Biotechnology
Jun 10, 2021 Transcarent
Series B $58M Health Care
Feb 22, 2021 Absci
Corporate Round Artificial Intelligence Yes